Eisler Capital Management’s Blueprint Medicines BPMC Stock Holding History

Eisler Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,198	Closed	-$10M	–	850
2025 Q2	$10M	Buy	+78,198	New	+$8.12M	0.06%	270

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eisler Capital Management's BPMC Position: Q3 2025 in Review

Eisler Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 78,198 shares — an estimated $10M sold.

Eisler Capital Management first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $10M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Eisler Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Eisler Capital Management sold 78,198 Blueprint Medicines shares in Q3 2025, an estimated $10M.
Eisler Capital Management first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
Eisler Capital Management's Blueprint Medicines position peaked at $10M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.